Cisatracurium Besylate 2 mg/ml Suppliers & Bulk Manufacturers
Available Forms: Injection
Available Strengths: 2 mg/ml
Reference Brands: Nimbex (USA/EU)
Category: Anaesthetics
Cisatracurium besylate is a nondepolarizing skeletal neuromuscular blocker for intravenous administration. Compared to other neuromuscular blockers, it is intermediate in its onset and duration of action.
Product Description:
Cisatracurium besilate undergoes Hofmann elimination which makes this as a drug of choice in organ failure patients. Keywords:Cisatracurium, Neuromuscular blocking agent, Nondepolarizing. Introduction blockers are available General anesthesia (GA) is commonly practiced due to various disadvantages seen with regional techniques.
Cisatracurium Besylate — third party manufacturing & bulk supply
Cisatracurium Besylate 2 mg/ml is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:
What to include when you enquire
- Destination market — determines which manufacturers hold the right site-level approvals
- First order quantity and estimated annual volume
- Whether you need a registration dossier or the product is already registered
- Packaging, labelling and language requirements
- Incoterms and required shelf life
Manufacturers of Cisatracurium Besylate listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding. Narcotic drugs and controlled substances are supplied strictly against valid import and export permits issued by the competent authorities.
Request a quote for Cisatracurium Besylate →The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Frequently Asked Questions
Cisatracurium besylate is used as a neuromuscular blocking agent to facilitate tracheal intubation and provide skeletal muscle relaxation during surgical procedures or in intensive care settings for mechanically ventilated patients.
Cisatracurium besylate is a synthetic benzylisoquinolinium compound formulated as the besylate (benzene sulfonate) salt. It is manufactured through controlled pharmaceutical chemical synthesis.
The primary trade name is Nimbex in the USA, UK, and EU, along with generic versions.
Nimbex has been marketed by pharmaceutical companies such as GlaxoSmithKline and later by other licensed manufacturers depending on the region. Generic versions are produced by multiple manufacturers worldwide.
The generic name is cisatracurium besylate.
The main brand name is Nimbex.
Cisatracurium besylate injection is manufactured by various pharmaceutical companies in the USA, UK, EU, India, and other countries, depending on the brand or generic manufacturer.
Related Products
Sufentanil Citrate
Strength:
50 mcg/mL, 100 mcg/mL, 15 mcg
Form: Tablet / Injection
Reference Brands: Sufenta (USA/EU), Dsuvia (USA/EU)
View Details
Pancuronium Bromide
Strength:
1 mg/mL, 2 mg/mL
Form: Injection
Reference Brands: Pavulon (USA/EU)
View Details
Dyclonine Hydrochloride
Strength:
0.5% w/v, 1% w/v
Form: topical solution/ lozenges / sprays
Reference Brands: Sucrets Complete (USA)
View Details
Droperidol
Strength:
2.5 mg/mL , 5 mg/mL
Form: Injection
Reference Brands: Droleptan (EU)
View DetailsQuick Response Guaranteed | Verified Suppliers
